Allergies Archives - MedCity News

FDA Rejects ARS Pharma’s Nasal Spray Alternative to Injectable Epinephrine

Frank Vinluan — Wed, 20 Sep 2023 17:51:20 +0000

ARS Pharmaceuticals frames its intranasal epinephrine spray as a needle-free alternative to products such as EpiPen. Though this spray won the backing of an FDA advisory committee, the agency is now requiring that ARS Pharma run another study to support a regulatory submission.

Allermi Raises $3.5M in Seed Funding To Grow DTC Allergy Relief Platform

Marissa Plescia — Tue, 21 Mar 2023 22:30:14 +0000

Allermi’s $3.5 million seed funding was led by Nelstone Ventures and included participation from FourSight Capital Partners. The company will use the money to expand nationally.

Online allergy startup raises $1.25M in pre-seed round

Joel Berg — Fri, 09 Sep 2022 18:48:03 +0000

Based in San Francisco, Allermi aims to create a national market for a customizable approach to allergy relief pioneered by a California doctor.

Imagine a world without disease [Sponsored]

Stephanie Baum — Mon, 08 Nov 2021 12:30:36 +0000

The team behind the World Without Disease Accelerator, part of Janssen Research & Development, one of the Janssen Pharmaceutical companies of Johnson & Johnson, is embracing an ambitious paradigm focused on disease prevention, interception and cure.

EverlyWell garners $2M to add more tests, staff for diagnostic testing startup

Josh Baxt — Wed, 03 May 2017 16:46:06 +0000

Julia Cheek, EverlyWell CEO and cofounder, said in an email that the funding will help the company expand its suite of tests, hire key leadership positions, launch new partnerships and enhance product features this year.

Allergy diagnostics market to reach $3.8bn by 2024

Juliet Preston — Sun, 23 Oct 2016 23:57:50 +0000

Rising rates of allergies worldwide will cause the global market for allergy diagnostics to nearly triple from $1.3 billion in 2015 to $3.8 billion in 2024, says a new report.

7 biotech and medtech companies confronting the rise of food allergies

Josh Baxt — Tue, 28 Jun 2016 16:19:34 +0000

From immunotherapies to mobile health apps, here’s how biotech and medtech companies are responding to the rising number of children with food allergies.

Innovation is in progress to replace the bulky EpiPen with something more practical

Nicole Oran — Wed, 02 Sep 2015 13:00:58 +0000

There must be some better, more efficient solutions for the essential use of the EpiPen, and Windgap Medical is working on it.

Morning Read: Abbott readies $25B bid for St Jude Medical, research suggests potential for allergy-free public parks

Nicole Oran — Thu, 27 Aug 2015 11:55:17 +0000

Drug developer Abbott Laboratories is poised to make a $25 billion bid for medical device maker St Jude Medical, allergy free parks could be a thing in the future.

The best way to protect your kids from allergies: Let them play in the dirt

Nina Ruhe — Tue, 02 Jun 2015 10:30:50 +0000

Microbiologist Jason Tetro explains that the best way to protect your child against allergies is to let them get dirty.

Watch out, EpiPen: A better auto-injector for severe allergies is in the works

Meghana Keshavan — Tue, 02 Jun 2015 02:45:21 +0000

As allergies rise, so does the need for on-the-spot epinephrine treatment. Windgap Medical wants to win a chunk of this fast-growing, $1.3 billion market.

The business case for Sean Parker’s $24M gift to Stanford for allergy research

Meghana Keshavan — Wed, 17 Dec 2014 05:01:02 +0000

Tech entrepreneur Sean Parker just pledged $24 million to Stanford University to set up a new […]

Scientists developing potential cure for peanut allergies with surprising treatment: Peanuts

Stephanie Baum — Sat, 01 Feb 2014 14:28:40 +0000

Nietzsche may have been thinking of emotional turmoil when he wrote “That which does not […]

Smartphone as epidemiologist: App + cradle can detect food toxins and tainted water

Lindsey Alexander — Thu, 01 Aug 2013 18:19:51 +0000

A new smartphone biosensor may provide particularly helpful point-of-care possibilities for medicine in remote locations […]